CEO of Paragon Biosciences On Why Innovation In Pharma Is Hard
Jeffrey Aronin, chairman and CEO of Paragon Biosciences, spoke with Chief Executive about why healthcare is stagnant from an innovation standpoint, the importance in doing meaningful work and more.